Cite
Chitosan-sialic acid nanoparticles of selenium: Statistical optimization of production, characterization, and assessment of cytotoxic effects against two human glioblastoma cell lines.
MLA
Abadi, Banafshe, et al. “Chitosan-Sialic Acid Nanoparticles of Selenium: Statistical Optimization of Production, Characterization, and Assessment of Cytotoxic Effects against Two Human Glioblastoma Cell Lines.” International Journal of Pharmaceutics, vol. 637, Apr. 2023, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.ijpharm.2023.122884.
APA
Abadi, B., Khazaeli, P., Forootanfar, H., Ranjbar, M., Ahmadi-Zeidabadi, M., Nokhodchi, A., Ameri, A., Adeli-Sardou, M., & Amirinejad, M. (2023). Chitosan-sialic acid nanoparticles of selenium: Statistical optimization of production, characterization, and assessment of cytotoxic effects against two human glioblastoma cell lines. International Journal of Pharmaceutics, 637, N.PAG. https://doi.org/10.1016/j.ijpharm.2023.122884
Chicago
Abadi, Banafshe, Payam Khazaeli, Hamid Forootanfar, Mehdi Ranjbar, Meysam Ahmadi-Zeidabadi, Ali Nokhodchi, Atefeh Ameri, Mahboubeh Adeli-Sardou, and Maryam Amirinejad. 2023. “Chitosan-Sialic Acid Nanoparticles of Selenium: Statistical Optimization of Production, Characterization, and Assessment of Cytotoxic Effects against Two Human Glioblastoma Cell Lines.” International Journal of Pharmaceutics 637 (April): N.PAG. doi:10.1016/j.ijpharm.2023.122884.